LUX
Biotronik Ag
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79226449 |
| Registration Number | 5548009 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | GABRIELLE S. ROTH |
| Attorney Name | GABRIELLE S. ROTH |
| Attorney Docket Number | S3473014 |
| Law Office Assigned | M60 |
| Employee Name | EINSTEIN, MATTHEW T |
Timeline
| 2017-11-15 | Application Filed |
| 2018-06-12 | Published for Opposition |
| 2018-08-28 | Location: PUBLICATION AND ISSUE SECTION |
| 2018-08-28 | Status: Live/Registered |
| 2018-08-28 | Trademark Registered |
| 2018-12-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  BIOTRONIK AG |
| Address | Ackerstrasse 6 CH-8180 Bülach CH |
| Legal Entity Type | Aktiengesellschaft (ag) |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0051 | Chemical and pharmaceutical preparations for medical purposes, namely, drug preparations for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; chemical and pharmaceutical drug delivery preparations in the form of coatings for medical devices and balloons that facilitate the delivery of pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, drug preparations for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; pharmaceutical preparations for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; drugs for medical purposes, namely, drugs for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; excipients, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for use in drug eluting balloons |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2018-02-08 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-02-09 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2018-02-13 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2018-02-27 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-02-28 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2018-03-01 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2018-03-07 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2018-03-07 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2018-03-24 | 9 RFNT P: |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2018-05-02 | 10 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2018-05-02 | 11 ARAA I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2018-05-07 | 12 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2018-05-07 | 13 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2018-05-07 | 14 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2018-05-07 | 15 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-05-07 | 16 CNSA O:Outgoing Correspondence |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2018-05-23 | 17 OP2R P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-05-23 | 18 NONP E:E-Mail |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2018-05-23 | 19 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2018-06-08 | 20 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2018-06-12 | 21 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-06-12 | 22 NPUB E:E-Mail |
| NEW REPRESENTATIVE AT IB RECEIVED | 2018-08-24 | 23 NREP P: |
| REGISTERED-PRINCIPAL REGISTER | 2018-08-28 | 24 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2018-11-28 | 25 FICR P: |
| FINAL DISPOSITION PROCESSED | 2018-12-08 | 26 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2018-12-08 | 27 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2018-12-28 | 28 FINO P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2021-06-05 | 29 NREP P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2021-09-18 | 30 NREP P: |
| COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | 2023-08-28 | 31 REM3 E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 